Adagio Medical
Developing innovative cryoablation technologies that create continuous, linear, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation.
Launch date
Employees
Market cap
-
Enterprise valuation
€155—232m (Dealroom.co estimates Nov 2020.)
Laguna Hills California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $2.5m | Seed | |
N/A | $4.1m | Early VC | |
N/A | $7.0m | Early VC | |
$42.5m | Series E | ||
* | N/A | $9.5m | Debt |
* | $130m | SPAC IPO | |
Total Funding | €51.0m |
Recent News about Adagio Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.